Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cunningham

Showing results (801-810 of 1,101) with videos related to

Pageof 111
Sort By:
British Journal of Cancer|April 7, 2005
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphomaM Ng, J Waters, D Cunningham, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphomaN L Gilchrist, J Caldwell, I D Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trialsE Mitry, J-Y Douillard, E Van Cutsem, et al.
American Journal of Surgery|June 1, 1997
Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancerJ D Cunningham, G K Schwartz, M Karpeh, et al.
Infection and Immunity|January 1, 1997
Identification of CD14 residues involved in specific lipopolysaccharide recognitionR A Shapiro, M D Cunningham, K Ratcliffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinomaL Assersohn, G Brown, D Cunningham, et al.
Medical & Biological Engineering & Computing|July 1, 1992
Cardiac stimulator for the study of refractory period control using current pulses of programmable duration and shapeM Spicer, D L Pitty, K Boone, et al.
The Journal of Clinical Investigation|August 1, 1992
Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activityR P Darveau, J Blake, C L Seachord, et al.
Journal of Neurochemistry|January 1, 1991
Inhibitors of urokinase and thrombin in cultured neural cellsS L Wagner, A L Lau, A Nguyen, et al.
Gut|March 13, 2003
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastasesN C Tebbutt, A R Norman, D Cunningham, et al.
Pageof 111

Showing results (801-810 of 1,101) with videos related to

Sort By:
Pageof 111
British Journal of Cancer|April 7, 2005
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphomaM Ng, J Waters, D Cunningham, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphomaN L Gilchrist, J Caldwell, I D Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trialsE Mitry, J-Y Douillard, E Van Cutsem, et al.
American Journal of Surgery|June 1, 1997
Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancerJ D Cunningham, G K Schwartz, M Karpeh, et al.
Infection and Immunity|January 1, 1997
Identification of CD14 residues involved in specific lipopolysaccharide recognitionR A Shapiro, M D Cunningham, K Ratcliffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinomaL Assersohn, G Brown, D Cunningham, et al.
Medical & Biological Engineering & Computing|July 1, 1992
Cardiac stimulator for the study of refractory period control using current pulses of programmable duration and shapeM Spicer, D L Pitty, K Boone, et al.
The Journal of Clinical Investigation|August 1, 1992
Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activityR P Darveau, J Blake, C L Seachord, et al.
Journal of Neurochemistry|January 1, 1991
Inhibitors of urokinase and thrombin in cultured neural cellsS L Wagner, A L Lau, A Nguyen, et al.
Gut|March 13, 2003
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastasesN C Tebbutt, A R Norman, D Cunningham, et al.
Pageof 111